Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells

Takanori Watanabe, Masayoshi Hioki, Toshiya Fujiwara, Masahiko Nishizaki, Shunsuke Kagawa, Masaki Taki, Hiroyuki Kishimoto, Yoshikatsu Endo, Yasuo Urata, Noriaki Tanaka, Toshiyoshi Fujiwara

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Replication-competent oncolytic viruses are being developed for human cancer therapy. We previously reported that an attenuated adenovirus OBP-301 (Telomelysin), in which the human telomerase reverse transcriptase promoter element drives expression of E1A and E1B genes linked with an internal ribosome entry site, could replicate in and causes selective lysis of human cancer cells. Infection efficiency in target cancer cells is the most important factor that predicts the antitumor effects of OBP-301. The objectives of this study are to examine the effects of the histone deacetylase inhibitor FR901228 on the level of coxsackie and adenovirus receptor (CAR) expression and OBP-301-mediated oncolysis in human non-small cell lung cancer cell lines. Flow cytometric analysis revealed up-regulated CAR expression in A549 and H460 cells following treatment with 1 ng/ml of FR901228, which was associated with increased infection efficiency as confirmed by replication-deficient β-galactosidase- expressing adenovirus vector. In contrast, neither CAR expression nor infection efficiency was affected by FR901228 in H1299 cells. To visualize and quantify viral replication in the presence of FR901228, we used OBP-401 (Telomelysin-GFP) that expresses the green fluorescent protein (GFP) reporter gene under the control of the cytomegalovirus promoter in the E3 region. Fluorescence microscopy and flow cytometry showed that FR901228 increased GFP expression in A549 and H460 cells following OBP-401 infection in a dose-dependent manner, but this effect did not occur in H1299 cells. In addition, OBP-301 and FR901228 demonstrated a synergistic antitumor effect in A549 cells in vitro, as confirmed by isobologram analysis. Our data indicate that FR901228 preferentially increases adenovirus infectivity via up-regulation of CAR expression, leading to a profound oncolytic effect, which may have a significant impact on the outcome of adenovirus-based oncolytic virotherapy.

Original languageEnglish
Pages (from-to)256-265
Number of pages10
JournalExperimental Cell Research
Volume312
Issue number3
DOIs
Publication statusPublished - Feb 1 2006

Fingerprint

Histone Deacetylase Inhibitors
Telomerase
Coxsackie and Adenovirus Receptor-Like Membrane Protein
Lung Neoplasms
Adenoviridae
Green Fluorescent Proteins
Infection
Oncolytic Virotherapy
Galactosidases
Oncolytic Viruses
Neoplasms
romidepsin
Cytomegalovirus
Reporter Genes
Fluorescence Microscopy
Non-Small Cell Lung Carcinoma
Flow Cytometry
Up-Regulation
Cell Line
Therapeutics

Keywords

  • Adenovirus
  • CAR
  • HDAC inhibitor
  • Lung cancer
  • Oncolytic virus

ASJC Scopus subject areas

  • Cell Biology

Cite this

Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells. / Watanabe, Takanori; Hioki, Masayoshi; Fujiwara, Toshiya; Nishizaki, Masahiko; Kagawa, Shunsuke; Taki, Masaki; Kishimoto, Hiroyuki; Endo, Yoshikatsu; Urata, Yasuo; Tanaka, Noriaki; Fujiwara, Toshiyoshi.

In: Experimental Cell Research, Vol. 312, No. 3, 01.02.2006, p. 256-265.

Research output: Contribution to journalArticle

Watanabe, Takanori ; Hioki, Masayoshi ; Fujiwara, Toshiya ; Nishizaki, Masahiko ; Kagawa, Shunsuke ; Taki, Masaki ; Kishimoto, Hiroyuki ; Endo, Yoshikatsu ; Urata, Yasuo ; Tanaka, Noriaki ; Fujiwara, Toshiyoshi. / Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells. In: Experimental Cell Research. 2006 ; Vol. 312, No. 3. pp. 256-265.
@article{c474288dc5fc4133a4c57fecda8c08f7,
title = "Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells",
abstract = "Replication-competent oncolytic viruses are being developed for human cancer therapy. We previously reported that an attenuated adenovirus OBP-301 (Telomelysin), in which the human telomerase reverse transcriptase promoter element drives expression of E1A and E1B genes linked with an internal ribosome entry site, could replicate in and causes selective lysis of human cancer cells. Infection efficiency in target cancer cells is the most important factor that predicts the antitumor effects of OBP-301. The objectives of this study are to examine the effects of the histone deacetylase inhibitor FR901228 on the level of coxsackie and adenovirus receptor (CAR) expression and OBP-301-mediated oncolysis in human non-small cell lung cancer cell lines. Flow cytometric analysis revealed up-regulated CAR expression in A549 and H460 cells following treatment with 1 ng/ml of FR901228, which was associated with increased infection efficiency as confirmed by replication-deficient β-galactosidase- expressing adenovirus vector. In contrast, neither CAR expression nor infection efficiency was affected by FR901228 in H1299 cells. To visualize and quantify viral replication in the presence of FR901228, we used OBP-401 (Telomelysin-GFP) that expresses the green fluorescent protein (GFP) reporter gene under the control of the cytomegalovirus promoter in the E3 region. Fluorescence microscopy and flow cytometry showed that FR901228 increased GFP expression in A549 and H460 cells following OBP-401 infection in a dose-dependent manner, but this effect did not occur in H1299 cells. In addition, OBP-301 and FR901228 demonstrated a synergistic antitumor effect in A549 cells in vitro, as confirmed by isobologram analysis. Our data indicate that FR901228 preferentially increases adenovirus infectivity via up-regulation of CAR expression, leading to a profound oncolytic effect, which may have a significant impact on the outcome of adenovirus-based oncolytic virotherapy.",
keywords = "Adenovirus, CAR, HDAC inhibitor, Lung cancer, Oncolytic virus",
author = "Takanori Watanabe and Masayoshi Hioki and Toshiya Fujiwara and Masahiko Nishizaki and Shunsuke Kagawa and Masaki Taki and Hiroyuki Kishimoto and Yoshikatsu Endo and Yasuo Urata and Noriaki Tanaka and Toshiyoshi Fujiwara",
year = "2006",
month = "2",
day = "1",
doi = "10.1016/j.yexcr.2005.10.026",
language = "English",
volume = "312",
pages = "256--265",
journal = "Experimental Cell Research",
issn = "0014-4827",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells

AU - Watanabe, Takanori

AU - Hioki, Masayoshi

AU - Fujiwara, Toshiya

AU - Nishizaki, Masahiko

AU - Kagawa, Shunsuke

AU - Taki, Masaki

AU - Kishimoto, Hiroyuki

AU - Endo, Yoshikatsu

AU - Urata, Yasuo

AU - Tanaka, Noriaki

AU - Fujiwara, Toshiyoshi

PY - 2006/2/1

Y1 - 2006/2/1

N2 - Replication-competent oncolytic viruses are being developed for human cancer therapy. We previously reported that an attenuated adenovirus OBP-301 (Telomelysin), in which the human telomerase reverse transcriptase promoter element drives expression of E1A and E1B genes linked with an internal ribosome entry site, could replicate in and causes selective lysis of human cancer cells. Infection efficiency in target cancer cells is the most important factor that predicts the antitumor effects of OBP-301. The objectives of this study are to examine the effects of the histone deacetylase inhibitor FR901228 on the level of coxsackie and adenovirus receptor (CAR) expression and OBP-301-mediated oncolysis in human non-small cell lung cancer cell lines. Flow cytometric analysis revealed up-regulated CAR expression in A549 and H460 cells following treatment with 1 ng/ml of FR901228, which was associated with increased infection efficiency as confirmed by replication-deficient β-galactosidase- expressing adenovirus vector. In contrast, neither CAR expression nor infection efficiency was affected by FR901228 in H1299 cells. To visualize and quantify viral replication in the presence of FR901228, we used OBP-401 (Telomelysin-GFP) that expresses the green fluorescent protein (GFP) reporter gene under the control of the cytomegalovirus promoter in the E3 region. Fluorescence microscopy and flow cytometry showed that FR901228 increased GFP expression in A549 and H460 cells following OBP-401 infection in a dose-dependent manner, but this effect did not occur in H1299 cells. In addition, OBP-301 and FR901228 demonstrated a synergistic antitumor effect in A549 cells in vitro, as confirmed by isobologram analysis. Our data indicate that FR901228 preferentially increases adenovirus infectivity via up-regulation of CAR expression, leading to a profound oncolytic effect, which may have a significant impact on the outcome of adenovirus-based oncolytic virotherapy.

AB - Replication-competent oncolytic viruses are being developed for human cancer therapy. We previously reported that an attenuated adenovirus OBP-301 (Telomelysin), in which the human telomerase reverse transcriptase promoter element drives expression of E1A and E1B genes linked with an internal ribosome entry site, could replicate in and causes selective lysis of human cancer cells. Infection efficiency in target cancer cells is the most important factor that predicts the antitumor effects of OBP-301. The objectives of this study are to examine the effects of the histone deacetylase inhibitor FR901228 on the level of coxsackie and adenovirus receptor (CAR) expression and OBP-301-mediated oncolysis in human non-small cell lung cancer cell lines. Flow cytometric analysis revealed up-regulated CAR expression in A549 and H460 cells following treatment with 1 ng/ml of FR901228, which was associated with increased infection efficiency as confirmed by replication-deficient β-galactosidase- expressing adenovirus vector. In contrast, neither CAR expression nor infection efficiency was affected by FR901228 in H1299 cells. To visualize and quantify viral replication in the presence of FR901228, we used OBP-401 (Telomelysin-GFP) that expresses the green fluorescent protein (GFP) reporter gene under the control of the cytomegalovirus promoter in the E3 region. Fluorescence microscopy and flow cytometry showed that FR901228 increased GFP expression in A549 and H460 cells following OBP-401 infection in a dose-dependent manner, but this effect did not occur in H1299 cells. In addition, OBP-301 and FR901228 demonstrated a synergistic antitumor effect in A549 cells in vitro, as confirmed by isobologram analysis. Our data indicate that FR901228 preferentially increases adenovirus infectivity via up-regulation of CAR expression, leading to a profound oncolytic effect, which may have a significant impact on the outcome of adenovirus-based oncolytic virotherapy.

KW - Adenovirus

KW - CAR

KW - HDAC inhibitor

KW - Lung cancer

KW - Oncolytic virus

UR - http://www.scopus.com/inward/record.url?scp=29144485434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29144485434&partnerID=8YFLogxK

U2 - 10.1016/j.yexcr.2005.10.026

DO - 10.1016/j.yexcr.2005.10.026

M3 - Article

C2 - 16356494

AN - SCOPUS:29144485434

VL - 312

SP - 256

EP - 265

JO - Experimental Cell Research

JF - Experimental Cell Research

SN - 0014-4827

IS - 3

ER -